Elucidation of the interaction of AMPK and insulin signalling, and their roles in FAK regulation, may lead to novel therapeutic strategies for chronic diseases as seemingly disparate as type 2 diabetes and cancer. This evidence concerns the gene INS and type 2 diabetes mellitus.